Yes, Rebif Is Administered via Self-Injection
Rebif (interferon beta-1a) is injected subcutaneously by patients themselves, typically three times a week. It comes in prefilled syringes or a reusable autoinjector called RebiSmart, which simplifies the process for home use.[1]
How Do You Inject Rebif?
Patients pinch the skin on the thigh, abdomen, buttock, or upper arm, insert the needle at a 90-degree angle, and inject the full dose over about 30 seconds. The RebiSmart device automates needle insertion and injection, with visual and audio cues. Training from a healthcare provider is standard before starting.[1][2]
What If Self-Injection Feels Difficult?
Some patients use assistance from caregivers or switch to the autoinjector if manual syringes cause issues like needle anxiety. Injection-site reactions (redness, pain) affect up to 80% initially but often improve; rotating sites helps.[2]
How Does Rebif Compare to Other MS Injectables?
Unlike oral options like fingolimod (Gilenya), Rebif requires self-injection, similar to Avonex (intramuscular, weekly) or Betaseron (subcutaneous, every other day). Copaxone uses a daily self-injection but has a different peptide mechanism.[3]
Who Makes Rebif and What's the Dosing?
EMD Serono (a Merck KGaA subsidiary) manufactures it for relapsing multiple sclerosis. Starting dose is usually 22 mcg or 44 mcg three times weekly, titrated up over four weeks to reduce flu-like symptoms.[1]
[1]: Rebif.com - Administration
[2]: MS Society - Rebif Guide
[3]: Drugs.com - MS Treatments Comparison